RayzeBio, a Bristol Myers Squibb company, is developing transformative radiopharmaceutical therapies for cancer patients.
Base: $77,846 - $94,332; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified